HBLRX
Price
$14.60
Change
+$0.05 (+0.34%)
Updated
Apr 2 closing price
Net Assets
11.99B
RMYCX
Price
$9.33
Change
-$0.03 (-0.32%)
Updated
Apr 2 closing price
Net Assets
285.24M
Ad is loading...

HBLRX vs RMYCX

Header iconHBLRX vs RMYCX Comparison
Open Charts HBLRX vs RMYCXBanner chart's image
Hartford Balanced Income R3
Price$14.60
Change+$0.05 (+0.34%)
VolumeN/A
Net Assets11.99B
Russell Inv Multi-Strategy Income C
Price$9.33
Change-$0.03 (-0.32%)
VolumeN/A
Net Assets285.24M
HBLRX vs RMYCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HBLRX vs. RMYCX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLRX is a Buy and RMYCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
HBLRX has more cash in the bank: 12B vs. RMYCX (285M). RMYCX pays higher dividends than HBLRX: RMYCX (4.33) vs HBLRX (2.96). HBLRX was incepted earlier than RMYCX: HBLRX (15 years) vs RMYCX (10 years). RMYCX (1.92) is less costly to investors than HBLRX (1.28). RMYCX is a more actively managed with annual turnover of: 88.00 vs. HBLRX (61.00). HBLRX (0) and RMYCX (0) have matching initial minimum investment requirements. RMYCX annual gain was more profitable for investors over the last year : 5.60 vs. HBLRX (3.94). RMYCX (27.12) and HBLRX (26.28) have equivalent 5 years return.
HBLRXRMYCXHBLRX / RMYCX
Total Expense Ratio1.281.7573%
Annual Report Gross Expense Ratio1.281.9267%
Fund Existence15 years10 years-
Gain YTD2.8242.303123%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets12B285M4,211%
Annual Yield % from dividends2.964.3368%
Returns for 1 year3.945.6070%
Returns for 3 years2.762.37117%
Returns for 5 years26.2827.1297%
Returns for 10 years30.68N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTLLX25.500.31
+1.23%
Glenmede Disciplined US Growth Eq Ptf
HSIDX11.54N/A
N/A
Hartford Schroders Sust Intl Core SDR
GICIX13.14N/A
N/A
Goldman Sachs Intl Sm Cp Insghts Instl
ASISX26.78N/A
N/A
Invesco EQV Asia Pacific Equity R6
PAXGX15.89N/A
N/A
Impax Global Opportunities Investor